A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

NCT07553299 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight
Weight Maintenance

Interventions

DRUG: VRB-101
DRUG: Placebo

Sponsor

Verdiva Bio Dev Limited